Lenticulostriated vasculopathy is a high-risk marker for hearing loss in congenital cytomegalovirus infections

Acta Paediatrica, International Journal of Paediatrics

Volumn 104, Issue 9, 2015, Pages e388-e394

  Bilavsky, Efraim ^a,b   Schwarz, Michael ^a,b   Pardo, Joseph ^b,c   Attias, Joseph ^a,d   Levy, Itzhak ^a,b   Haimi Cohen, Yishai ^a,b   Amir, Jacob ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d UNIVERSITY OF HAIFA   (Israel)

Author keywords

Brain; Congenital infection; Cytomegalovirus; Hearing loss; Lenticulostriated vasculopathy

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR; ANTIVIRUS AGENT;

ARTICLE; ASYMPTOMATIC DISEASE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DETERIORATION; HEARING IMPAIRMENT; HEARING TEST; HUMAN; INFANT; LENTICULOSTRIATED VASCULOPATHY; MAJOR CLINICAL STUDY; NEUTROPENIA; NEWBORN PERIOD; PRIORITY JOURNAL; ULTRASOUND; VASCULAR DISEASE; ANALOGS AND DERIVATIVES; BASAL GANGLIA CEREBROVASCULAR DISEASE; COMPLICATION; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEARING LOSS; MALE; NEWBORN; RETROSPECTIVE STUDY; RISK FACTOR;

ANTIVIRAL AGENTS; BASAL GANGLIA CEREBROVASCULAR DISEASE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEARING LOSS; HUMANS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84939257930     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.13053     Document Type: Article

References (26)

1. Wang HS, Kuo MF, Chang TC,. Sonographic lenticulostriate vasculopathy in infants: some associations and a hypothesis. AJNR Am J Neuroradiol 1995; 16: 97-102.
2. Amir J, Schwarz M, Levy I, Haimi-Cohen Y, Pardo J,. Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection? Arch Dis Child 2011; 96: 846-50.
3. Makhoul IR, Eisenstein I, Sujov P, Soudack M, SMolkin T, Tamir A, et al., Neonatal lenticulostriate vasculopathy: further characterisation. Arch Dis Child Fetal Neonatal Ed 2003; 88: F410-4.
4. Lombardi G, Garofoli F, Stronati M,. Congenital cytomegalovirus infection: treatment, sequelae and follow-up. J Matern Fetal Neonatal Med 2010; 23: 45-8.
5. de Jong EP, Lopriore E, Vossen AC, Steggerda SJ, Te Pas AB, Kroes AC, et al., Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy? Neonatology 2010; 97: 274-8.
6. El Ayoubi M, de Bethmann O, Monset-Couchard M,. Lenticulostriate echogenic vessels: clinical and sonographic study of 70 neonatal cases. Pediatr Radiol 2003; 33: 697-703.
7. Tomà P, Magnano GM, Mezzano P, Lazzini F, Bonacci W, Serra G,. Cerebral ultrasound images in prenatal cytomegalovirus infection. Neuroradiology 1989; 31: 278-9.
8. Ben-Ami T, Yousefzadeh D, Backus M, Reichman B, Kessler A, Hammerman-Rozenberg C,. Lenticulostriate vasculopathy in infants with infections of the central nervous system sonographic and Doppler findings. Pediatr Radiol 1990; 20: 575-9.
9. de Vries LS, Gunardi H, Barth PG, Bok LA, Verboon-Maciolek MA, Groenendaal F,. The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection. Neuropediatrics 2004; 35: 113-9.
10. Peled Y, Yogev Y, Oron G, Amir J, Pardo J,. Suggested algorithm for cytomegalovirus surveillance in low-risk pregnancies. J Matern Fetal Neonatal Med 2011; 24: 1353-6.
11. Amir J, Wolf DG, Levy I,. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr 2010; 169: 1061-7.
12. Hughes P, Weinberger E, Shaw DW,. Linear areas of echogenicity in the thalami and basal ganglia of neonates: an expanded association. Work in progress. Radiology 1991; 179: 103-5.
13. Weber K, Riebel T, Nasir R,. Hyperechoic lesions in the basal ganglia: an incidental sonographic finding in neonates and infants. Pediatr Radiol 1992; 22: 182-6.
14. Cabañas F, Pellicer A, Morales C, Garcia-Alix A, Stiris TA, Quero J,. New pattern of hyperechogenicity in thalamus and basal ganglia studied by color Doppler flow imaging. Pediatr Neurol 1994; 10: 109-16.
15. Coley BD, Rusin JA, Boue DR,. Importance of hypoxic/ischemic conditions in the development of cerebral lenticulostriate vasculopathy. Pediatr Radiol 2000; 30: 846-55.
16. Haataja L, Mercuri E, Cowan F, Dubowitz L,. Cranial ultrasound abnormalities in full term infants in a postnatal ward: outcome at 12 and 18 months. Arch Dis Child Fetal Neonatal Ed 2000; 82: F128-33.
17. Mercuri E, Dubowitz L, Brown SP, Cowan F,. Incidence of cranial ultrasound abnormalities in apparently well neonates on a postnatal ward: correlation with antenatal and perinatal factors and neurological status. Arch Dis Child Fetal Neonatal Ed 1998; 79: F185-9.
18. Gover A, Bader D, Weinger-Abend M, Chystiakov I, Miller E, Riskin A, et al., Head ultrasonograhy as a screening tool in apparently healthy asymptomatic term neonates. Isr Med Assoc J 2011; 13: 9-13.
19. Heibel M, Heber R, Bechinger D, Kornhuber HH,. Early diagnosis of perinatal cerebral lesions in apparently normal full-term newborns by ultrasound of the brain. Neuroradiology 1993; 35: 85-91.
20. Wang LW, Huang CC, Yeh TF,. Major brain lesions detected on sonographic screening of apparently normal term neonates. Neuroradiology 2004; 46: 368-73.
21. Boppana SB, Fowler KB, Vaid Y, et al., Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997; 99: 409-14.
22. Capretti MG, Lanari M, Tani G, Ancora G, Sciutti R, Marsico C, et al., Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection. Brain Dev 2013; 36: 203-11.
23. Ancora G, Lanari M, Lazzarotto T, Venturi V, Tridapalli E, Sandri F, et al., Cranial ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection. J Pediatr 2007; 150: 157-61.
24. Kimberlin DW, Lin CY, Sánchez PJ, Demmler Gj, Dankner W, Shelton M, et al., Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143: 16-25.
25. Stronati M, Lombardi G, Garofoli F, Villani P, Regazzi M,. Pharmacokinetics, pharmacodynamics and clinical use of valganciclovir in newborns with symptomatic congenital cytomegalovirus infection. Curr Drug Metab 2013; 14: 208-15.
26. del Rosal T, Baquero-Artigao F, Blázquez D, Noguera-Julian A, Moreno-Perez D, Reyes A, et al., Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period. J Clin Virol 2012; 55: 72-4.